Precision combo slashes rectal cancer treatment side effects?
NCT ID NCT07161115
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 28 times
Summary
This study tests a new approach for people with locally advanced rectal cancer. Instead of standard large-field radiation before surgery, it uses MRI-guided, short-course radiation targeted only at the tumor, combined with immunotherapy and chemotherapy. The goal is to reduce side effects and lower the risk of cancer spreading, while keeping local control rates high. About 60 adults aged 18-75 with a specific type of rectal cancer will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.